The US government recently unveiled a $2 billion investment initiative targeting quantum computing firms, offering $100 million equity stakes in various startups. These capital injections represent potentially pivotal moments for companies still years from commercial viability. However, Representative Zoe Lofgren (D-Calif.), ranking member of the House Science, Space, and Technology Committee, has raised significant legal objections to the program’s structure.

Representative Lofgren contends these investments violate the intended purpose of the CHIPS and Science Act, which allocated funds specifically for microelectronics research and semiconductor development. She argues that quantum processing technology overlaps insufficiently with semiconductor manufacturing to justify the reallocation of these designated resources.

Furthermore, Lofgren emphasizes that the act was designed to foster public-private research partnerships, a model these direct equity investments do not follow. She has also highlighted concerns regarding the distribution of funds, noting that IBM stands to receive the largest portion of the investment while former IBM executive Dario Gil, now Under Secretary for Science at the Department of Energy, was reportedly involved in negotiation processes.

Despite these criticisms, Lofgren clarified that her objections are not a judgment on the value of quantum technology investments or the merits of the companies involved. Rather, she maintains that such initiatives would require explicit congressional authorization and appropriation to proceed legally.

Source link

Exit mobile version